Join
Live feed
·
INSIDERFilingvia Quantisnow
Ocular Therapeutix Inc. logo

Chief Development Officer Kaiser Peter sold $24,329 worth of shares (2,967 units at $8.20), decreasing direct ownership by 1% to 266,141 units (SEC Form 4) to satisfy withholding obligation

ByQuantisnow·Wall Street's wire, on your screen.
OCUL· Ocular Therapeutix Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OCUL (Ocular Therapeutix Inc.) and more on Quantisnow.